课题基金 / 基金详情

The pathophysiology of malignant glioma and of treatment strategies

The pathophysiology of malignant glioma and of treatment strategies
恶性胶质瘤的病理生理学和治疗策略
批准号:
14370439
负责人:
KURATSU Jun-ichi
金额:
$8.96万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004

项目摘要

项目成果

KURATSU Jun-ichi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1.Vascular endothelial growth factor(VEGF) play an important role in the angiogenesis of glioma. We found that there are two mechanisms of angiogenesis by VEGF in malignant glioma, one is via VEGF produced by macrophages infiltrated by monocyte chemoattractant protein 1(MCP-1) derived from glioma cells and the other is via VEGF stimulated by thrombin converted from pro-thrombin derived from glioma cells. Furthermore, we found that docosahexaenoic acid contained in the necrotic tissue suppressed the antitumor activity of macrophages infiltrated in the glioma.2.We reported that the increased activity and expression of Integrin-linked kinase(ILK) activity is regulated by PTEN. The transfection into the glioblastoma cells altered the localization of ILK in the cell membrane ; transfection with PTEN down-regulated PKB/Akt phosphorylation of ILK-singnaling. We assume that ILK is critical for the PTEN-sensitive regulation of PKB/Akt-dependent cell survival. The COX-2 inhibitor was capable of down-regulating ILK and PKB/Akt phosphorylation.3.We retrospectively analyzed the relationship between treatment outcomes and EGF-R gene, homozygous deletion of p16 gene in newly diagnosed glioblastoma adult patients. We found that EGF-R and homozygous deletion of p16 gene are of significant prognostic value for predicting survival in glioblastoma patients.4.Neurofibromin which is a NF1 gene product. We found the mutural regulation of cellular neurofibromin is essential for normal neuronal differentiation and that abnormal regulation in neuronal cells may be implicated in NF1-related learning and memory disturbance.
期刊论文(64)
专著(0)
科研奖励(0)
会议论文
N.Shinojima: "Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme."Cancer Res.. 63・20. 6962-6970 (2003)
N.Shinojima:“表皮生长因子受体对多形性胶质母细胞瘤患者的预后价值”。Cancer Res.63・20(2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GAP function toward Ras.
神经纤维瘤病 I 型肿瘤抑制神经纤维蛋白通过其针对 Ras 的 GAP 功能调节神经元分化。
DOI: --
发表时间: 2003
期刊: J.Biol.Chem. 278
影响因子: --
作者: [S.Yunoue, H.Tokuo, K.Fukunaga, L.Feng, T.Ozawa, T.Nishi, A.Kikuchi, S.Hattori, J.Kuratsu, H.Saya, N.Araki]
通讯作者: N.Araki
Expression and distribution of c-kit receptor and its ligand in human CNS germ cell tumors : a useful histological marker for the diagnosis of germinoma.
c-kit受体及其配体在人中枢神经系统生殖细胞肿瘤中的表达和分布:诊断生殖细胞瘤的有用组织学标志物。
DOI: --
发表时间: 2004
期刊: Brain Tumor Pathology 21
影响因子: --
作者: [Youichi Saitoh, 富永 篤, 有田 和徳, Kato Amami, Eguchi Yutaka, Arita K, Saitoh Y, 富永 篤, Saitoh Y, Tomishima T, 有田 和徳, Yenomas DC, Soichi Obara, Kanou Y, 二宮宏智, Arita K, Hideo Takeshima]
通讯作者: Hideo Takeshima
Preliminary observations on genetic alterations in pilocytic astrocytomas associated with neurofibromatosis 1.
与神经纤维瘤病相关的毛细胞型星形细胞瘤基因改变的初步观察1.
DOI: --
发表时间: 2003
期刊: Neuro-Oncology 5
影响因子: --
作者: [Kenji Tada]
通讯作者: Kenji Tada
25
    Development of new anti-tumor therapy for malignant glioma using a drug incorporating polymeric micelle attached with a specific antibody for glioma cancer stem cell
    • 批准号:
      23390351
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.15万
    • 财政年份:
      2011
    • 负责人:
      KURATSU Jun-ichi
    • 依托单位:
    Deep brain stimulation and neuronal reorganization
    • 批准号:
      20591714
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2008
    • 负责人:
      KURATSU Jun-ichi
    • 依托单位:
    The pathophysiology of malignant glioma and treatment strategies
    • 批准号:
      17390404
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.59万
    • 财政年份:
      2005
    • 负责人:
      KURATSU Jun-ichi
    • 依托单位:
    The study of the pathophysiology of malignant glioma and development of treatment strategies
    • 批准号:
      11470293
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.28万
    • 财政年份:
      1999
    • 负责人:
      KURATSU Jun-ichi
    • 依托单位:
    国内基金
    海外基金
    PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
    • 批准号:
      82371651
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      赵栋
    • 依托单位:
    TIPE2调控巨噬细胞M2极化改善睑板腺功能障碍的作用机制研究
    • 批准号:
      82371028
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      赵慧
    • 依托单位:
    IL-4协同精氨酸优化种植初期巨噬细胞胞葬作用和成骨微环境的作用及机制研究
    • 批准号:
      82370923
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      张文杰
    • 依托单位:
    NPM1表观重塑巨噬细胞代谢及修复表型在心肌缺血损伤中的调控作用
    • 批准号:
      82371825
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      占贞贞
    • 依托单位: